Ryan Henrici

Senior Director of Translational Research @BigHat Biosciences

Leading therapeutic programme strategy, target identification, and antibody discovery, optimisation, and in vivo evaluation for a variety of next generation antibody formats across oncology, I&I, and rare diseases. Key contributor to intellectual property protection, business development, and other corporate activities. Major focus on T cell engagers, ADCs, and multispecific designs.